[The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia].
Lipid peroxidation, antioxidant system and hemorheology were studied in the course of ceruloplasmin treatment given to 47 patients with ischemic heart disease (IHD). Coupled changes in the above systems seem to be involved in pathogenesis of IHD variants. Ceruloplasmin effectively inhibits lipid peroxidation, corrects hemorheological disorders, improves IHD running.
Zakirova
A N
AN
Mingazetdinova
L N
LN
Kamilov
F Kh
FKh
Lankin
V Z
VZ
Lebedev
A V
AV
Konovalova
G G
GG
D000328:Adult; D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy*; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy*; D000975:Antioxidants / Q000627:therapeutic use*; D001809:Blood Viscosity / Q000187:drug effects*; D002570:Ceruloplasmin / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000627:therapeutic use; D012074:Remission Induction
D000975:Antioxidants; D003692:Delayed-Action Preparations; D009566:Nitrates; D002570:Ceruloplasmin
Antioksidant tseruloplazmin: vliianie na perekisnoe okislenie lipidov, gemoreologiiu i techenie stenokardii.